211. Hypoplastic left heart syndrome
20 clinical trials,   28 drugs   (DrugBank: 9 drugs),   5 drug target genes,   13 drug target pathways
Searched query = "Hypoplastic left heart syndrome", "HLHS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03431480 (ClinicalTrials.gov) | February 16, 2018 | 30/1/2018 | Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery | Safety Study of Autologous Cord Blood Stem Cell Treatment in Hypoplastic Left Heart Syndrome Patients Undergoing the Norwood Heart Operation | Hypoplastic Left Heart Syndrome;Heart Defects, Congenital;Pediatric Disorder | Biological: Autologous Human Placental Cord Blood Mononuclear Cells | Murdoch Childrens Research Institute | NULL | Recruiting | N/A | 4 Days | All | 12 | Phase 1 | Australia |